Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 μg ethinyl estradiol and 3 mg drospirenone

  1. Milsom, I.
  2. Lete, I.
  3. Bjertnaes, A.
  4. Rokstad, K.
  5. Lindh, I.
  6. Gruber, C.J.
  7. Birkhäuser, M.H.
  8. Aubeny, E.
  9. Knudsen, T.
  10. Bastianelli, C.
Revue:
Human Reproduction

ISSN: 1460-2350,  0268-1161

Année de publication: 2006

Volumen: 21

Número: 9

Pages: 2304-2311

Type: Article

DOI: 10.1093/HUMREP/DEL162 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objetivos de desarrollo sostenible

La source de données: Scopus